Research ExplorerJournalsJ DRUGS DERMATOL Publications

J DRUGS DERMATOL - Journal of Drugs in Dermatology

1 - 3 out of 3Page size: 50

Publications

  1. 2022

  2. Early Response is Associated With Stable Long-Term Response in Psoriasis Patients Receiving Ixekizumab or Ustekinumab

    Augustin, M., Gallo, G., See, K., McKean-Matthews, M., Burge, R., Gooderham, M. & Reich, K., 01.02.2022, In: J DRUGS DERMATOL. 21, 2, p. 122-126 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2018

  4. Mechanisms Underlying the Clinical Effects of Apremilast for Psoriasis

    Pincelli, C., Schafer, P. H., French, L. E., Augustin, M. & Krueger, J. G., 01.08.2018, In: J DRUGS DERMATOL. 17, 8, p. 835-840 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  5. 2012

  6. PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.

    Papp, K. A., Strober, B., Augustin, M., Calabro, S., Londhe, A., Chevrier, M., Investigators, PSOLAR. & Committee, S., 2012, In: J DRUGS DERMATOL. 11, 10, p. 1210-1217 10.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review